Pharmacokinetic Interactions between HIV-1 Protease Inhibitors in Rats: Study on Combinations of Two Kinds of HIV-1 Protease Inhibitors
β Scribed by NOBUHITO SHIBATA; YASUHIRO MATSUMURA; HIROYUKI OKAMOTO; YUKO KAWAGUCHI; AKIKO OHTANI; YUKAKO YOSHIKAWA; KANJI TAKADA
- Book ID
- 111768567
- Publisher
- Pharmaceutical Press
- Year
- 2000
- Tongue
- English
- Weight
- 113 KB
- Volume
- 52
- Category
- Article
- ISSN
- 2042-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Recently, as a new type of antiβAIDS drug, an HIVβ1 protease inhibitor, KNIβ174, has been synthesized; it shows a potent and selective HIVβ1 protease inhibitory activity __in vitro__. In this study, we developed an HPLC assay system for KNIβ174 in rat plasma and examined the pharmacokin
The interaction between HIV-1 protease and reversible inhibitors was studied by surface plasmon resonance biosensor technology. The steady-state binding level and the time course of association and dissociation could be observed by measuring the binding of inhibitors injected in a continuous flow of
The objective was to examine the influence of Pluronic block-copolymers on the interaction between the drug efflux transporter, P-glycoprotein and HIV-1 protease inhibitors (PIs). The ATPase assay determined the effect of various Pluronics on PI-stimulated P-gp ATPase activity. Cellular accumulation